Skip to main content
| News

Escientia Switzerland becomes Primopus

13.10.2022

The Indian company Deccan Fine Chemicals is acquiring Escientia Switzerland and renaming it as Primopus AG. The new owner announces investments in the Basel Area production facility. The Swiss subsidiary of America’s Escientia Life Sciences Group was established in the Basel region in 2020.

Primopus, formerly Escientia Switzerland, is based at the Getec Park in Pratteln (img: Getec Park.swiss)

Deccan Fine Chemicals Private Ltd has announced the acquisition of Escientia Switzerland AG. In future, it will be called Primopus. Escientia, the Swiss subsidiary of the U.S. company Escientia Life Sciences Group, was established in 2020 with the support of Standortförderung Baselland and the location and innovation promotion agency Basel Area Business & Innovation.

According to a press release, Deccan, one of the world’s largest contract development and manufacturing organizations (CDMO), will be investing in a production plant taken over from Novartis spanning 17,000 square meters as part of this acquisition. It is expected to become operational in the second half of 2023.

Supply chain for pharmaceutical industry

According to the information provided, Primopus will focus on providing a hybrid supply chain for the pharmaceutical industry from its location at Getec Park in Pratteln in the canton of Basel-Landschaft. This will be linked to Deccan’s three large fine chemical sites in India. Furthermore, Deccan has announced that Primopus will further develop its research and development capacities.

Marcel Velterop has been named as the CEO. He commented that he is certain that bridging the skills and capabilities of the Swiss operation with the large talent and capacity pool in India will bring unique value and assurance to global players in the pharma supply chain, especially in the current geopolitical environment.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Basel Area Business & Innovation, ICT, Innovation, Invest

UptownBasel joins IBM Quantum Network

UptownBasel is partnering with IBM. The emerging competence center for Industry 4.0 will provide its partners with the IBM Quantum...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech, Switzerland Innovation Park

South Korean pharma firms show interest in the Basel Area

Several South Korean firms from the life sciences industry, including three pharmaceutical multinationals, have visited the Basel Area on fact-finding...

Read More
Gamma Technologies acquires ProFEMAG portfolio
Advanced Manufacturing/AI, Basel Area Business & Innovation, ICT, Innovation, Invest

Gamma Technologies acquires ProFEMAG portfolio

The Basel-based firm ProFEMAG AG has sold its FEMAG software for electrical machine applications to Gamma Technologies. The company based...

Read More
Basel Area Business & Innovation, ICT, Innovation, Invest, Life Sciences / biotech

Databaum establishes headquarters in Basel

Databaum is establishing its headquarters in Basel and plans to grow from its location there. The startup provides the agricultural...

Read More
Clinerion launches patient information platform
Basel Area Business & Innovation, Digital Health, ICT, Innovation, Invest, Life Sciences / biotech

Clinerion launches patient information platform

Basel-based Clinerion is introducing its machine learning platform. It comprises a global network of hospitals and enables researchers to recognize...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech, Switzerland Innovation Park

New innovation campus opens in the Basel Area

The Main Campus of the Switzerland Innovation Park Basel Area was officially opened on October 29. In his speech, Federal...

Read More
1 2 3 59

Do you have a question? We'd like to hear from you.